Literature DB >> 17267225

Synthesis and evaluation of 2',4',6'-trihydroxychalcones as a new class of tyrosinase inhibitors.

Nishida Jun1, Gao Hong, Kawabata Jun.   

Abstract

In this study, we synthesized a series of hydroxychalcones and examined their tyrosinase inhibitory activity. The results showed that 2',4',6'-trihydroxychalcone (1), 2,2',3,4',6'-pentahydroxychalcone (4), 2',3,4,4',5,6'-hexahydroxychalcone (5), 2',4',6'-trihydroxy- 3,4-dimethoxychalcone (9) and 2,2',4,4',6'-pentahydroxychalcone (15) exhibited high inhibitory effects on tyrosinase with respect to l-tyrosine as a substrate. By the structure-activity relationship study, it was suggested that the 2',4',6'-trihydroxyl substructure in the chalcone skeleton were efficacious for the inhibition of tyrosinase activity. And also, the catechol structure on B-ring of chalcones was not advantageous for the inhibitory potency. Furthermore, 15 (IC(50)=1microM) was found to show the highest activity out of a set of 15 hydroxychalcones, even better than both 2,2',4,4'-tetrahydroxychalcone (13, IC(50)=5microM) and kojic acid (16, IC(50)=12microM), which were known as potent tyrosinase inhibitors. Kinetic study revealed that 15 acts as a competitive inhibitor of tyrosinase with K(i) value of 3.1microM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17267225     DOI: 10.1016/j.bmc.2007.01.017

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  12 in total

Review 1.  Paving the way towards effective plant-based inhibitors of hyaluronidase and tyrosinase: a critical review on a structure-activity relationship.

Authors:  Jakub Gębalski; Filip Graczyk; Daniel Załuski
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

2.  Hydroxylated chalcones with dual properties: Xanthine oxidase inhibitors and radical scavengers.

Authors:  Emily Hofmann; Jonathan Webster; Thuy Do; Reid Kline; Lindsey Snider; Quintin Hauser; Grace Higginbottom; Austin Campbell; Lili Ma; Stefan Paula
Journal:  Bioorg Med Chem       Date:  2015-12-17       Impact factor: 3.641

3.  (E)-3-(4-Eth-oxy-phen-yl)-1-(2-hy-droxy-phen-yl)prop-2-en-1-one.

Authors:  Jirapa Horkaew; Suchada Chantrapromma; Nisakorn Saewan; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-08-18

4.  Synthesis of xanthohumol and xanthohumol-d3 from naringenin.

Authors:  Joanna Andrusiak; Kinga Mylkie; Małgorzata Wysocka; Jacek Ścianowski; Andrzej Wolan; Marcin Budny
Journal:  RSC Adv       Date:  2021-08-31       Impact factor: 4.036

Review 5.  Upregulation of Melanogenesis and Tyrosinase Activity: Potential Agents for Vitiligo.

Authors:  Chao Niu; Haji A Aisa
Journal:  Molecules       Date:  2017-08-04       Impact factor: 4.411

Review 6.  An updated review of tyrosinase inhibitors.

Authors:  Te-Sheng Chang
Journal:  Int J Mol Sci       Date:  2009-05-26       Impact factor: 6.208

7.  Antimicrobial Activities of Some Pyrazoline and Hydrazone Derivatives.

Authors:  Begüm Evranos AksÖz; Suna Sibel GÜrpinar; Müjde Eryilmaz
Journal:  Turk J Pharm Sci       Date:  2020-10-30

8.  (E)-1-[2-Hy-droxy-4,6-bis-(meth-oxy-meth-oxy)phen-yl]-3-phenyl-prop-2-en-1-one.

Authors:  Chao Niu; Y Q Liu; Y W He; H A Aisa
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-04-13

9.  Diverse Molecular Targets for Chalcones with Varied Bioactivities.

Authors:  Bo Zhou; Chengguo Xing
Journal:  Med Chem (Los Angeles)       Date:  2015-08-22

10.  Functionality study of chalcone-hydroxypyridinone hybrids as tyrosinase inhibitors and influence on anti-tyrosinase activity.

Authors:  L Ravithej Singh; Yu-Lin Chen; Yuan-Yuan Xie; Wei Xia; Xing-Wen Gong; Robert C Hider; Tao Zhou
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.